New evidence sheds light on the risk of postoperative bone loss among pre- and post-menopausal women with a BRCA mutation who undergo bilateral salpingo-oophorectomy, as well as the potential role of...
The FDA has approved Baqsimi nasal powder, the first glucagon therapy for the emergency treatment of severe hypoglycemia that can be administered without an injection.
Because many adults with diabetes are undiagnosed, researchers sought to examine the effects of routine outpatient random plasma glucose testing on rates of diabetes diagnosis in a retrospective cohort...
While statins are one of the most widely prescribed medications worldwide, concerns about the drugs’ associations with dysglycemia and new-onset diabetes still remain.
In a study presented at the American Diabetes Association’s 79th Scientific Sessions, researchers aimed to investigate the effects of a certain sodium-glucose co-transporter-2 inhibitor on kidney disease...
While previous studies have suggested that lower blood 25-hydroxyvitamin D levels are associated with the risk of type 2 diabetes, whether supplementation could affect this association is still unknown. ...
In a new study, CDC scientists evaluated trends in the incidence and prevalence of diagnosed type 1 and type 2 diabetes from 1980 to 2017. Some findings were encouraging, while others highlight areas of...
Because of the common nature of non-alcoholic fatty liver disease and the chance of progression to non-alcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma, researchers sought to estimate the...
New guidelines from an international group of methodologists, general practitioners, internists, endocrinologists, and patient partners with subclinical hypothyroidism could, if implemented,...
Previous research has indicated that use of sodium-glucose cotransporter-2 inhibitors could be associated with a rare urologic necrotizing infection. In a recent analysis, the FDA sought to further examine...
